# OnCo record paper-clarke-nejm-evid (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-clarke-nejm-evid/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-clarke-nejm-evid" ;
  schema:name "Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer"@en ;
  schema:description "Paper cited by one pairing page, indexed on Europe PMC as PubMed record 38319800 and published in NEJM Evidence; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-clarke-nejm-evid/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/evidoa2200043>, <https://pubmed.ncbi.nlm.nih.gov/38319800/>, <https://europepmc.org/article/MED/38319800> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/evidoa2200043> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Clarke NW, Armstrong AJ, Thiery-Vuillemin A, et al." ;
  onco:related <https://onco.cc/pairings/parp-plus-arpi/> ;
  onco:journals <https://onco.cc/journals/nejm-evidence/> .